These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 21896306)
21. The cholinergic system and Parkinson disease. Bohnen NI; Albin RL Behav Brain Res; 2011 Aug; 221(2):564-73. PubMed ID: 20060022 [TBL] [Abstract][Full Text] [Related]
22. Neuroimaging approaches to cognition in Parkinson's disease. Montaser-Kouhsari L; Young CB; Poston KL Prog Brain Res; 2022; 269(1):257-286. PubMed ID: 35248197 [TBL] [Abstract][Full Text] [Related]
23. PET studies in Parkinson's disease motor and cognitive dysfunction. Pavese N Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S96-9. PubMed ID: 22166468 [TBL] [Abstract][Full Text] [Related]
24. Correlation of dopamine transporter imaging with parkinsonian motor handicap: how close is it? Pirker W Mov Disord; 2003 Oct; 18 Suppl 7():S43-51. PubMed ID: 14531046 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease. Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007 [TBL] [Abstract][Full Text] [Related]
26. The predictive value of transcranial sonography in clinically diagnosed patients with early stage Parkinson's disease: comparison with DAT PET scans. Liu P; Li X; Li FF; Ou-Yang QH; Zhang HX; Feng T Neurosci Lett; 2014 Oct; 582():99-103. PubMed ID: 25218716 [TBL] [Abstract][Full Text] [Related]
27. Assessment of neuroimaging techniques as biomarkers of the progression of Parkinson's disease. Brooks DJ; Frey KA; Marek KL; Oakes D; Paty D; Prentice R; Shults CW; Stoessl AJ Exp Neurol; 2003 Nov; 184 Suppl 1():S68-79. PubMed ID: 14597329 [TBL] [Abstract][Full Text] [Related]
28. Cardiovascular dysautonomia in Parkinson disease: from pathophysiology to pathogenesis. Jain S; Goldstein DS Neurobiol Dis; 2012 Jun; 46(3):572-80. PubMed ID: 22094370 [TBL] [Abstract][Full Text] [Related]
29. Abnormal ventral tegmental area-anterior cingulate cortex connectivity in Parkinson's disease with depression. Wei L; Hu X; Yuan Y; Liu W; Chen H Behav Brain Res; 2018 Jul; 347():132-139. PubMed ID: 29530489 [TBL] [Abstract][Full Text] [Related]
30. Neuroimaging: current role in detecting pre-motor Parkinson's disease. Godau J; Hussl A; Lolekha P; Stoessl AJ; Seppi K Mov Disord; 2012 Apr; 27(5):634-43. PubMed ID: 22508281 [TBL] [Abstract][Full Text] [Related]
31. Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI. Massa F; Arnaldi D; De Cesari F; Girtler N; Brugnolo A; Grazzini M; Bauckneht M; Meli R; Morbelli S; Pardini M; Sambuceti G; De Carli F; Tiraboschi P; Nobili F Neurobiol Aging; 2019 Apr; 76():9-17. PubMed ID: 30611093 [TBL] [Abstract][Full Text] [Related]
32. The role of biomarkers and imaging in Parkinson's disease. Algarni MA; Stoessl AJ Expert Rev Neurother; 2016; 16(2):187-203. PubMed ID: 26829357 [TBL] [Abstract][Full Text] [Related]
33. Correlation of Parkinson disease severity and 18F-DTBZ positron emission tomography. Hsiao IT; Weng YH; Hsieh CJ; Lin WY; Wey SP; Kung MP; Yen TC; Lu CS; Lin KJ JAMA Neurol; 2014 Jun; 71(6):758-66. PubMed ID: 24756323 [TBL] [Abstract][Full Text] [Related]
34. The role of neuroimaging in the diagnosis of the atypical parkinsonian syndromes in clinical practice. Dąbrowska M; Schinwelski M; Sitek EJ; Muraszko-Klaudel A; Brockhuis B; Jamrozik Z; Sławek J Neurol Neurochir Pol; 2015; 49(6):421-31. PubMed ID: 26652877 [TBL] [Abstract][Full Text] [Related]
35. Imaging biomarkers in Parkinson's disease and Parkinsonian syndromes: current and emerging concepts. Saeed U; Compagnone J; Aviv RI; Strafella AP; Black SE; Lang AE; Masellis M Transl Neurodegener; 2017; 6():8. PubMed ID: 28360997 [TBL] [Abstract][Full Text] [Related]
36. Dopaminergic modulation of resting-state functional connectivity in de novo patients with Parkinson's disease. Baik K; Cha J; Ham JH; Baek GM; Sunwoo MK; Hong JY; Shin NY; Kim JS; Lee JM; Lee SK; Sohn YH; Lee PH Hum Brain Mapp; 2014 Nov; 35(11):5431-41. PubMed ID: 24938993 [TBL] [Abstract][Full Text] [Related]
37. Usefulness of a dopamine transporter PET ligand [(18)F]beta-CFT in assessing disability in Parkinson's disease. Rinne JO; Ruottinen H; Bergman J; Haaparanta M; Sonninen P; Solin O J Neurol Neurosurg Psychiatry; 1999 Dec; 67(6):737-41. PubMed ID: 10567489 [TBL] [Abstract][Full Text] [Related]